Cointime

Aevi Genomic Medicine

company

About

Aevi Genomic Medicine focuses on translating genetic discoveries into novel therapies.

  • 11 - 50

Highlights

Total Funding Amount
$28M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
$28M
Industries
Biopharma,Biotechnology,Health Care,Life Science
Founded date
Jan 1, 2000
Number Of Employee
11 - 50
Operating Status
Active

Aevi Genomic Medicine focuses on translating genetic discoveries into novel therapies. It is dedicated to unlocking the potential of genomic medicine to translate genetic discoveries into novel therapies.

Driven by a commitment to patients with pediatric onset life-altering diseases, the company's research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics at The Children's Hospital of Philadelphia.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$28M
Aevi Genomic Medicine has raised a total of $28M in funding over 2 rounds. Their latest funding was raised on Oct 17, 2017 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 17, 2017 Post-IPO Equity $28M 1 The Children's Hospital of Philadelphia — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Aevi Genomic Medicine is funded by 1 investors. The Children's Hospital of Philadelphia are the most recent investors.
Investor Name Lead Investor Funding Round
The Children's Hospital of Philadelphia Yes Post-IPO Equity
Cointime
เนื้อหา
บริษัท